New Approvals – Page 5 – media

Two Approvals for AstraZeneca in Japan

The immunotherapy drug was approved for lung cancer patients with no chance for surgery whose cancer had not yet spread to other parts of the body.
- Source: Reuters
- 1,030
- July 3, 2018
breast cancer Japan lung cancer New Approvals
V920 Vaccination Against Ebola Outbreak Proves a Great Success

In the latest Ebola outbreak, a total of 61 cases were recorded and 28 lives were claimed in the Congo region. But now the World Health Organization has reported that the spread of this Ebola outbreak has "largely been contained" after the success of Merck's late-stage vaccination campaign for more than a month.
- Source: FiercePharma
- 803
- June 29, 2018
Ebola New Approvals vaccines
Array BioPharma gets FDA Approval for Melanoma Combo

The U.S, Based Array BioPharma received FDA approval for its much-awaited BRAFTOVI capsules with the combination of MEKTOVI tablets for the treatment of patients with metastatic melanoma with a BRAFV600E or BRAFV600K mutation.
- Source: FiercePharma
- 603
- June 28, 2018
cancer Melanoma New Approvals
Brain U Online Delays Dementia

The subscription-based consumer-friendly service named Brain U Online provides cognitive tasks with exercise to delay the progression of dementia by 2.5 years and reduce its negative effect by 45%.
- Source: MobiHealthNews
- 744
- June 28, 2018
Dementia mHealth New Approvals
FDA Approval for Eversense – Continuous Glucose Monitoring System

The FDA has finally approved to market the implantable continuous glucose monitoring system named Eversense, from Senseonics, in the United States.
- Source: MobiHealthNews
- 985
- June 27, 2018
diabetes digital health mHealth New Approvals
FDA Approval for Cannabis Based Epidiolex Medicine Against Seizures

Epidiolex, also known as purified cannabidiol was approved to treat Lennox-Gastaut syndrome and Dravet syndrome specifically in patients aged 2 and older. Both these conditions start during childhood. Recurrent seizures pose a huge risk of death.
- Source: FiercePharma
- 575
- June 27, 2018
FDA Medical marijuana New Approvals
Glaukos Corporation to receive Pre-Market approval for Next-Gen iStent

The inject is developed to achieve the natural outflow of aqueous humor by making two patent bypasses through the trabecular meshwork, glaucomatous eyes the main source of resistance resulting in multi-directional flow through Schlemm’s canal
- Source: BioSpectrumAsia
- 562
- June 26, 2018
FDA medtech New Approvals Optometry
AstraZeneca’s Durvalumab Receives Go-Ahead from DCGI to Market in India

Last Friday, pharma giant AstraZeneca announced that it had received the go-ahead from the Drug Controller General of India (DCGI) to import and market durvalumab (ImfinziTM) in India. The receipt of this permission paves the way for the launch of durvalumab (ImfinziTM) in India. Durvalumab which is a patented drug of Astra-Zeneca, received permission in India to provide treatment for patients with unresectable non-small cell lung cancer and metastatic urothelial carcinoma.
- Source: United News of India
- 2,563
- June 26, 2018
AstraZeneca cancer India New Approvals
FDA Approval for AI Enabled Diabetes Software

The Food and Drug Administration (FDA) has granted approval for a request made by DreaMed regarding their artificial intelligence-enabled diabetic software, which is exclusively meant for the providers, who are managing Type 1 diabetes patients.
- Source: MobiHealthNews
- 868
- June 20, 2018
AI digital health FDA New Approvals type 1 diabetes
Eye Movements Analysis for Parkinson’s Disease

A new robotic system called OSCANN Desk has been developed by researchers at Spain’s Universidad Politécnica de Madrid (UPM) and start-up AURA Innotive Robotics. The system has been designed for the accurate analysis of eye movements in order to detect neurodegenerative diseases such as Parkinson’s disease.
- Source: Verdict Medical Devices
- 682
- June 19, 2018
digital health machine learning New Approvals Parkinson’s disease

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.